Congenital anomaly of kidney and urinary tract
diseaseOn this page
Also known as CAKUTcongenital anomalies of kidney and urinary tractrenal or urinary tract malformation
Summary
Congenital anomaly of kidney and urinary tract (MONDO:0019719) is a disease caused by variants in LIFR, SHROOM4, and ZMYM2, with 75 cohort genes (1 GWAS associations across 4 studies) and 4 clinical trials. The dominant Reactome pathway is Formation of the ureteric bud (7 cohort genes).
At a glance
- Causal genes: LIFR (GenCC Strong), SHROOM4 (GenCC Strong), ZMYM2 (GenCC Strong)
- Cohort genes: 75
- GWAS associations: 1
- ClinVar variants: 176
- Clinical trials: 4
Clinical features
No curated clinical features (Orphanet) for this disease.
Identifiers
Disease identifiers
| Field | Value |
|---|---|
| Canonical name | congenital anomaly of kidney and urinary tract |
| Mondo ID | MONDO:0019719 |
| MeSH | C566906 |
| OMIM | 610805 |
| Orphanet | 93545 |
| DOID | DOID:0080205 |
| UMLS | C1968949 |
| MedGen | 369894 |
| GARD | 0019216 |
| Is cancer (heuristic) | no |
Also known as: CAKUT · congenital anomalies of kidney and urinary tract · congenital anomaly of kidney and urinary tract · renal or urinary tract malformation
Data availability: 176 ClinVar variants · 1 GWAS association (4 studies) · 19 GenCC gene-disease records.
Disease family
An umbrella term covering 3 Mondo subtypes.
Classification path: disease › human disease › disease by developmental or physiological process › disorder of development or morphogenesis › developmental defect during embryogenesis › congenital anomaly of kidney and urinary tract
Related subtypes (51): disorder of sexual differentiation, hereditary neurocutaneous angioma, nevoid basal cell carcinoma syndrome, angioosteohypertrophic syndrome, Larsen syndrome, schwannomatosis, linear nevus sebaceous syndrome, lethal Larsen-like syndrome, pseudodiastrophic dysplasia, focal dermal hypoplasia, microtia, neurofibromatosis-Noonan syndrome, Becker nevus syndrome, Legius syndrome, bone fragility with contractures, arterial rupture, and deafness, blindness - scoliosis - arachnodactyly syndrome, cutis laxa - Marfanoid syndrome, Maffucci syndrome, hydrops fetalis, ankyloblepharon filiforme-imperforate anus syndrome, developmental anomaly of metabolic origin, progeroid syndrome, facial cleft, Desbuquois dysplasia, cysts and fistulae of the face and oral cavity, macroglossia, middle ear anomaly, cleft palate, cutis laxa, infectious embryofetopathy, toxic or drug-related embryofetopathy, hemihyperplasia-multiple lipomatosis syndrome, phakomatosis pigmentokeratotica, phakomatosis pigmentovascularis, PTEN hamartoma tumor syndrome, marfanoid habitus-inguinal hernia-advanced bone age syndrome, neurofibromatosis type 1, multiple congenital anomalies/dysmorphic syndrome, congenital limb malformation, hereditary hemorrhagic telangiectasia, urogenital tract malformation, anotia, central nervous system malformation, Ehlers-Danlos syndrome, X-linked external auditory canal atresia-dilated internal auditory canal-facial dysmorphism syndrome, joint laxity, short stature, and myopia, diaphragmatic malformation, abdominal wall malformation, port-wine nevi-mega cisterna magna-hydrocephalus syndrome, conjoined twins, TP63-related ectodermal dysplasia spectrum with limb and orofacial malformations
Subtypes (3): congenital anomalies of kidney and urinary tract 1, congenital anomalies of kidney and urinary tract 2, congenital anomalies of kidney and urinary tract 3
Genetics & variants
GWAS landscape
1 GWAS associations across 4 studies. Top hits map to 0 distinct genes (as reported by GWAS).
Top associations by p-value
| rsID | p-value | Gene | Risk allele | Odds ratio |
|---|---|---|---|---|
| rs186637459 | 9e-09 | NUDT12 - NIHCOLE | ? |
Top studies (by case count)
| Study | Lead author | Year | Cases | Controls | Title |
|---|---|---|---|---|---|
| GCST90482460 | Verma A | 2024 | 488 | 450,295 | Diversity and scale: Genetic architecture of 2068 traits in the VA Million Veteran Program. |
| GCST90436763 | Zhou W | 2018 | 339 | 406,730 | Efficiently controlling for case-control imbalance and sample relatedness in large-scale genetic association studies. |
| GCST90436420 | Zhou W | 2018 | 213 | 397,602 | Efficiently controlling for case-control imbalance and sample relatedness in large-scale genetic association studies. |
| GCST90651455 | Liu TY | 2025 | 187 | 202,534 | Diversity and longitudinal records: Genetic architecture of disease associations and polygenic risk in the Taiwanese Han population. |
Variant details and genetic-evidence tiers
Tier distribution (top 50 variants)
| Tier | Variants |
|---|---|
| Tier 1: coding | 0 |
| Tier 2: splice/UTR | 0 |
| Tier 3: regulatory | 0 |
| Tier 4: intronic/intergenic | 1 |
MAF distribution
| Bucket | Variants |
|---|---|
| common (>=0.05) | 1 |
| low_freq (0.01-0.05) | 0 |
| rare (<0.01) | 0 |
| unknown | 0 |
Functional consequences
| Consequence | Count |
|---|---|
| intergenic_variant | 1 |
Top variants
| rsID | Chr | Pos | Alleles | MAF | Consequence | Gene | p-value | Tier |
|---|---|---|---|---|---|---|---|---|
| rs186637459 | 5 | 103947068 | A>T | 0.05 | intergenic_variant | NUDT12 - NIHCOLE | 9e-09 | Tier 4: intronic/intergenic |
ClinVar germline variants
176 retrieved; paginated sample, class counts are floors:
74 uncertain significance, 34 conflicting classifications of pathogenicity, 25 likely pathogenic, 17 pathogenic, 17 pathogenic/likely pathogenic, 5 benign/likely benign, 2 benign, 2 likely benign
| ClinVar | Variant (HGVS) | Gene | Classification | Review |
|---|---|---|---|---|
| 988100 | NM_000789.4(ACE):c.1709+5G>C | ACE | Pathogenic/Likely pathogenic | criteria provided, multiple submitters, no conflicts |
| 29585 | NM_001614.5(ACTG1):c.464C>T (p.Ser155Phe) | ACTG1 | Pathogenic | criteria provided, multiple submitters, no conflicts |
| 1307836 | NM_015557.3(CHD5):c.4852C>T (p.Arg1618Ter) | CHD5 | Pathogenic/Likely pathogenic | criteria provided, multiple submitters, no conflicts |
| 219099 | NM_015047.3(EMC1):c.2619_2622del (p.Pro874fs) | EMC1 | Pathogenic/Likely pathogenic | criteria provided, multiple submitters, no conflicts |
| 235484 | NM_025074.7(FRAS1):c.7551T>A (p.Tyr2517Ter) | FRAS1 | Pathogenic/Likely pathogenic | criteria provided, multiple submitters, no conflicts |
| 635698 | NM_000458.4(HNF1B):c.443C>T (p.Ser148Leu) | HNF1B | Pathogenic/Likely pathogenic | criteria provided, multiple submitters, no conflicts |
| 1344620 | NM_021828.5(HPSE2):c.1099-2A>G | HPSE2 | Pathogenic | no assertion criteria provided |
| 89 | NM_021828.5(HPSE2):c.457C>T (p.Arg153Ter) | HPSE2 | Pathogenic/Likely pathogenic | criteria provided, multiple submitters, no conflicts |
| 369648 | NM_001127671.2(LIFR):c.1273_1276del (p.Val425fs) | LIFR | Pathogenic | criteria provided, single submitter |
| 219378 | NM_017617.5(NOTCH1):c.1649dup (p.Tyr550Ter) | NOTCH1 | Pathogenic | criteria provided, multiple submitters, no conflicts |
| 1344621 | NM_001128178.3(NPHP1):c.1636del (p.Ser546fs) | NPHP1 | Pathogenic | no assertion criteria provided |
| 598394 | NM_153240.5(NPHP3):c.406del (p.Thr136fs) | NPHP3 | Pathogenic/Likely pathogenic | criteria provided, multiple submitters, no conflicts |
| 548653 | NM_003489.4(NRIP1):c.279del (p.Asp92_Trp93insTer) | NRIP1 | Pathogenic | no assertion criteria provided |
| 156297 | NM_000278.5(PAX2):c.76dup (p.Val26fs) | PAX2 | Pathogenic | criteria provided, multiple submitters, no conflicts |
| 41442 | NM_002834.5(PTPN11):c.178G>T (p.Gly60Cys) | PTPN11 | Pathogenic/Likely pathogenic | criteria provided, multiple submitters, no conflicts |
| 1077087 | NM_002941.4(ROBO1):c.4156G>T (p.Gly1386Ter) | ROBO1 | Pathogenic | criteria provided, single submitter |
| 1077089 | NM_002941.4(ROBO1):c.687C>G (p.Tyr229Ter) | ROBO1 | Pathogenic | criteria provided, single submitter |
| 1077090 | NM_002941.4(ROBO1):c.2758C>T (p.Arg920Ter) | ROBO1 | Pathogenic/Likely pathogenic | criteria provided, multiple submitters, no conflicts |
| 1321867 | NM_002941.4(ROBO1):c.2630_2631del (p.Pro877fs) | ROBO1 | Pathogenic | criteria provided, single submitter |
| 996027 | NM_002941.4(ROBO1):c.1198C>T (p.Gln400Ter) | ROBO1 | Pathogenic/Likely pathogenic | criteria provided, multiple submitters, no conflicts |
| 996034 | NM_002941.4(ROBO1):c.1342+1G>A | ROBO1 | Pathogenic | criteria provided, single submitter |
| 996098 | NM_002941.4(ROBO1):c.2882+1G>T | ROBO1 | Pathogenic | criteria provided, single submitter |
| 684623 | NM_004787.4(SLIT2):c.292G>A (p.Ala98Thr) | SLIT2 | Pathogenic | no assertion criteria provided |
| 684624 | NM_004787.4(SLIT2):c.2712A>T (p.Lys904Asn) | SLIT2 | Pathogenic | no assertion criteria provided |
| 208527 | NM_001080508.3(TBX18):c.1010del (p.Gly337fs) | TBX18 | Pathogenic/Likely pathogenic | no assertion criteria provided |
| 5578 | NM_014112.5(TRPS1):c.2795C>T (p.Ala932Val) | TRPS1 | Pathogenic | criteria provided, multiple submitters, no conflicts |
| 1264312 | NM_197968.4(ZMYM2):c.1618C>T (p.Arg540Ter) | ZMYM2 | Pathogenic | criteria provided, multiple submitters, no conflicts |
| 1264313 | NM_197968.4(ZMYM2):c.1607del (p.Cys536fs) | ZMYM2 | Pathogenic/Likely pathogenic | no assertion criteria provided |
| 1264314 | NM_197968.4(ZMYM2):c.766_767dup (p.Val256_Gly257insTer) | ZMYM2 | Pathogenic/Likely pathogenic | no assertion criteria provided |
| 1264315 | NM_197968.4(ZMYM2):c.2434_2437del (p.Lys812fs) | ZMYM2 | Pathogenic/Likely pathogenic | no assertion criteria provided |
Genes & proteins
Mendelian disease overlap and somatic drivers
GenCC: 67 · Orphanet: 151 · OMIM-shared: 0 · Dual-evidence (GWAS+Mendelian): 0
GenCC gene–disease validity (cohort genes)
the Disease column is the GenCC-asserted condition — a cohort gene’s strongest validity may be for a related predisposition syndrome.
| Gene | Classification | Inheritance | Disease | Records |
|---|---|---|---|---|
| LIFR | Strong | Autosomal dominant | congenital anomaly of kidney and urinary tract | 6 |
| SHROOM4 | Strong | X-linked | congenital anomaly of kidney and urinary tract | 5 |
| TBC1D1 | Strong | Autosomal dominant | non-syndromic renal or urinary tract malformation | 2 |
| ZMYM2 | Strong | Autosomal dominant | congenital anomaly of kidney and urinary tract | 6 |
| BCORL1 | Moderate | X-linked | congenital anomaly of kidney and urinary tract | 8 |
| BMP7 | Moderate | Autosomal dominant | multiple congenital anomalies/dysmorphic syndrome | 5 |
| SLIT2 | Moderate | Autosomal dominant | congenital anomaly of kidney and urinary tract | |
| SLIT3 | Moderate | Autosomal dominant | congenital anomaly of kidney and urinary tract | 2 |
| SRGAP1 | Moderate | Autosomal dominant | congenital anomaly of kidney and urinary tract | 2 |
| TSHZ3 | Moderate | Autosomal dominant | congenital anomaly of kidney and urinary tract | 3 |
| ARHGEF6 | Limited | X-linked | congenital anomaly of kidney and urinary tract | 8 |
| CHD1L | Limited | Unknown | congenital anomaly of kidney and urinary tract | |
| DLG5 | Limited | Autosomal recessive | congenital anomaly of kidney and urinary tract | 6 |
| SIX2 | Limited | Autosomal dominant | congenital anomaly of kidney and urinary tract | |
| TBC1D31 | Limited | Autosomal recessive | congenital anomaly of kidney and urinary tract | |
| TBX6 | Limited | Autosomal dominant | congenital anomaly of kidney and urinary tract | 6 |
| VWA2 | Limited | Autosomal recessive | congenital anomaly of kidney and urinary tract | |
| UPK3A | Disputed Evidence | Autosomal dominant | congenital anomaly of kidney and urinary tract | 3 |
Orphanet rare-disease linkage (cohort genes)
| Gene | Orphanet ID | Rare disease |
|---|---|---|
| SIX2 | Orphanet:488437 | SIX2-related frontonasal dysplasia |
| ZMYM2 | Orphanet:528084 | Non-specific syndromic intellectual disability |
| LIFR | Orphanet:3206 | Stüve-Wiedemann syndrome |
| TBX6 | Orphanet:1797 | Autosomal dominant spondylocostal dysostosis |
| TBX6 | Orphanet:2311 | Autosomal recessive spondylocostal dysostosis |
| UPK3A | Orphanet:93100 | Renal agenesis, unilateral |
| BCORL1 | Orphanet:528084 | Non-specific syndromic intellectual disability |
| SHROOM4 | Orphanet:85288 | X-linked intellectual disability, Stocco Dos Santos type |
| ARHGEF6 | Orphanet:777 | X-linked non-syndromic intellectual disability |
| ROBO1 | Orphanet:95496 | Pituitary stalk interruption syndrome |
| ROBO2 | Orphanet:289365 | Familial vesicoureteral reflux |
| SALL1 | Orphanet:857 | Townes-Brocks syndrome |
| SOX5 | Orphanet:313884 | 12p12.1 microdeletion syndrome |
| SOX5 | Orphanet:313892 | Developmental and speech delay due to SOX5 deficiency |
| SOX5 | Orphanet:626 | Large/giant congenital melanocytic nevus |
| HNF1B | Orphanet:1309 | Medullary sponge kidney |
| HNF1B | Orphanet:1331 | Familial prostate cancer |
| HNF1B | Orphanet:2578 | Mayer-Rokitansky-Küster-Hauser syndrome type 2 |
| HNF1B | Orphanet:261265 | 17q12 microdeletion syndrome |
| HNF1B | Orphanet:93111 | HNF1B-related autosomal dominant tubulointerstitial kidney disease |
| HNF1B | Orphanet:93172 | Renal dysplasia, unilateral |
| HNF1B | Orphanet:93173 | Renal dysplasia, bilateral |
| HNF1B | Orphanet:97363 | Unilateral multicystic dysplastic kidney |
| HNF1B | Orphanet:97364 | Bilateral multicystic dysplastic kidney |
| MED12 | Orphanet:1415 | Hardikar syndrome |
| MED12 | Orphanet:293707 | Blepharophimosis-intellectual disability syndrome, MKB type |
| MED12 | Orphanet:776 | Lujan-Fryns syndrome |
| MED12 | Orphanet:777 | X-linked non-syndromic intellectual disability |
| MED12 | Orphanet:93932 | FG syndrome type 1 |
| TRIO | Orphanet:476126 | Micrognathia-recurrent infections-behavioral abnormalities-mild intellectual disability syndrome |
| TRPS1 | Orphanet:502 | Trichorhinophalangeal syndrome type 2 |
| TRPS1 | Orphanet:77258 | Trichorhinophalangeal syndrome type 1 |
| TSC2 | Orphanet:210159 | Adult hepatocellular carcinoma |
| TSC2 | Orphanet:269001 | Isolated focal cortical dysplasia type IIa |
| TSC2 | Orphanet:269008 | Isolated focal cortical dysplasia type IIb |
| TSC2 | Orphanet:538 | Lymphangioleiomyomatosis |
| TSC2 | Orphanet:805 | Tuberous sclerosis complex |
| TSC2 | Orphanet:88924 | Autosomal dominant polycystic kidney disease type 1 with tuberous sclerosis |
| CACNA1D | Orphanet:324321 | Sinoatrial node dysfunction and deafness |
| CACNA1D | Orphanet:369929 | Primary hyperaldosteronism-seizures-neurological abnormalities syndrome |
| SHANK3 | Orphanet:662169 | Phelan-McDermid syndrome due to 22q13.3 deletion |
| SHANK3 | Orphanet:662172 | Phelan-McDermid syndrome due to SHANK3 mutation |
| ACTG1 | Orphanet:2995 | Baraitser-Winter cerebrofrontofacial syndrome |
| ACTG1 | Orphanet:90635 | Rare autosomal dominant non-syndromic sensorineural deafness type DFNA |
| ACTG1 | Orphanet:98942 | Coloboma of choroid and retina |
| ACTG1 | Orphanet:98944 | Coloboma of iris |
| GATA5 | Orphanet:3303 | Tetralogy of Fallot |
| GATA5 | Orphanet:334 | Hereditary atrial fibrillation |
| GATA5 | Orphanet:402075 | Familial bicuspid aortic valve |
| SALL4 | Orphanet:2307 | IVIC syndrome |
Cohort genes → proteins
75 cohort genes, 73 distinct canonical proteins.
Evidence partition
| Subset | Genes |
|---|---|
| multi_evidence | 75 |
Cohort genes (full)
| Symbol | HGNC | Ensembl | UniProt | Name | Evidence |
|---|---|---|---|---|---|
| BMP7 | HGNC:1074 | ENSG00000101144 | P18075 | Bone morphogenetic protein 7 | gencc,clinvar |
| SIX2 | HGNC:10888 | ENSG00000170577 | Q9NPC8 | Homeobox protein SIX2 | gencc,clinvar |
| SLIT2 | HGNC:11086 | ENSG00000145147 | O94813 | Slit homolog 2 protein | gencc,clinvar |
| SLIT3 | HGNC:11087 | ENSG00000184347 | O75094 | Slit homolog 3 protein | gencc,clinvar |
| TBC1D1 | HGNC:11578 | ENSG00000065882 | Q86TI0 | TBC1 domain family member 1 | gencc,clinvar |
| ZMYM2 | HGNC:12989 | ENSG00000121741 | Q9UBW7 | Zinc finger MYM-type protein 2 | gencc,clinvar |
| SRGAP1 | HGNC:17382 | ENSG00000196935 | Q7Z6B7 | SLIT-ROBO Rho GTPase-activating protein 1 | gencc,clinvar |
| CHD1L | HGNC:1916 | ENSG00000131778 | Q86WJ1 | ATP-dependent chromatin remodeler CHD1L | gencc,clinvar |
| TSHZ3 | HGNC:30700 | ENSG00000121297 | Q63HK5 | Teashirt homolog 3 | gencc,clinvar |
| LIFR | HGNC:6597 | ENSG00000113594 | P42702 | Leukemia inhibitory factor receptor | gencc,clinvar |
| TBX6 | HGNC:11605 | ENSG00000149922 | O95947 | T-box transcription factor TBX6 | gencc |
| UPK3A | HGNC:12580 | ENSG00000100373 | O75631 | Uroplakin-3a | gencc |
| VWA2 | HGNC:24709 | ENSG00000165816 | Q5GFL6 | von Willebrand factor A domain-containing protein 2 | gencc |
| BCORL1 | HGNC:25657 | ENSG00000085185 | Q5H9F3 | BCL-6 corepressor-like protein 1 | gencc |
| DLG5 | HGNC:2904 | ENSG00000151208 | Q8TDM6 | Disks large homolog 5 | gencc |
| SHROOM4 | HGNC:29215 | ENSG00000158352 | Q9ULL8 | Protein Shroom4 | gencc |
| TBC1D31 | HGNC:30888 | ENSG00000156787 | Q96DN5 | TBC1 domain family member 31 | gencc |
| ARHGEF6 | HGNC:685 | ENSG00000129675 | Q15052 | Rho guanine nucleotide exchange factor 6 | gencc |
| ROBO1 | HGNC:10249 | ENSG00000169855 | Q9Y6N7 | Roundabout homolog 1 | clinvar |
| ROBO2 | HGNC:10250 | ENSG00000185008 | Q9HCK4 | Roundabout homolog 2 | clinvar |
| SALL1 | HGNC:10524 | ENSG00000103449 | Q9NSC2 | Sal-like protein 1 | clinvar |
| SOX5 | HGNC:11201 | ENSG00000134532 | P35711 | Transcription factor SOX-5 | clinvar |
| TBX18 | HGNC:11595 | ENSG00000112837 | O95935 | T-box transcription factor TBX18 | clinvar |
| HNF1B | HGNC:11630 | ENSG00000275410 | P35680 | Hepatocyte nuclear factor 1-beta | clinvar |
| MED12 | HGNC:11957 | ENSG00000184634 | Q93074 | Mediator of RNA polymerase II transcription subunit 12 | clinvar |
| HSP90B2P | HGNC:12099 | ENSG00000259706 | Q58FF3 | Putative endoplasmin-like protein | clinvar |
| TRIO | HGNC:12303 | ENSG00000038382 | O75962 | Triple functional domain protein | clinvar |
| TRPS1 | HGNC:12340 | ENSG00000104447 | Q9UHF7 | Zinc finger transcription factor Trps1 | clinvar |
| TSC2 | HGNC:12363 | ENSG00000103197 | P49815 | Tuberin | clinvar |
| GET1 | HGNC:12790 | ENSG00000182093 | O00258 | Guided entry of tail-anchored proteins factor 1 | clinvar |
| CACNA1D | HGNC:1391 | ENSG00000157388 | Q01668 | Voltage-dependent L-type calcium channel subunit alpha-1D | clinvar |
| SHANK3 | HGNC:14294 | ENSG00000251322 | Q9BYB0 | SH3 and multiple ankyrin repeat domains protein 3 | clinvar |
| ACTG1 | HGNC:144 | ENSG00000184009 | P63261 | Actin, cytoplasmic 2 | clinvar |
| GATA5 | HGNC:15802 | ENSG00000130700 | Q9BWX5 | Transcription factor GATA-5 | clinvar |
| SALL4 | HGNC:15924 | ENSG00000101115 | Q9UJQ4 | Sal-like protein 4 | clinvar |
| TRAP1 | HGNC:16264 | ENSG00000126602 | Q12931 | Heat shock protein 75 kDa, mitochondrial | clinvar |
| CHD5 | HGNC:16816 | ENSG00000116254 | Q8TDI0 | ATP-dependent chromatin remodeler CHD5 | clinvar |
| CDON | HGNC:17104 | ENSG00000064309 | Q4KMG0 | Cell adhesion molecule-related/down-regulated by oncogenes | clinvar |
| CDC5L | HGNC:1743 | ENSG00000096401 | Q99459 | Cell division cycle 5-like protein | clinvar |
| KAT6B | HGNC:17582 | ENSG00000156650 | Q8WYB5 | Histone acetyltransferase KAT6B | clinvar |
| HPSE2 | HGNC:18374 | ENSG00000172987 | Q8WWQ2 | Inactive heparanase-2 | clinvar |
| KCNT1 | HGNC:18865 | ENSG00000107147 | Q5JUK3 | Potassium channel subfamily T member 1 | clinvar |
| NPHP4 | HGNC:19104 | ENSG00000131697 | O75161 | Nephrocystin-4 | clinvar |
| FRAS1 | HGNC:19185 | ENSG00000138759 | Q86XX4 | Extracellular matrix organizing protein FRAS1 | clinvar |
| BICC1 | HGNC:19351 | ENSG00000122870 | Q9H694 | Protein bicaudal C homolog 1 | clinvar |
| BCOR | HGNC:20893 | ENSG00000183337 | Q6W2J9 | BCL-6 corepressor | clinvar |
| COL4A1 | HGNC:2202 | ENSG00000187498 | P02462 | Collagen alpha-1(IV) chain | clinvar |
| MED13 | HGNC:22474 | ENSG00000108510 | Q9UHV7 | Mediator of RNA polymerase II transcription subunit 13 | clinvar |
| FAT4 | HGNC:23109 | ENSG00000196159 | Q6V0I7 | Protocadherin Fat 4 | clinvar |
| FREM1 | HGNC:23399 | ENSG00000164946 | Q5H8C1 | FRAS1-related extracellular matrix protein 1 | clinvar |
Cohort function summary
Lead sentence per gene, UniProt-curated.
| Symbol | Protein name | Function (lead sentence) |
|---|---|---|
| BMP7 | Bone morphogenetic protein 7 | Growth factor of the TGF-beta superfamily that plays important role in various biological processes, including embryogenesis, hematopoiesis, neurogenesis and skeletal morphogenesis. |
| SIX2 | Homeobox protein SIX2 | Transcription factor that plays an important role in the development of several organs, including kidney, skull and stomach. |
| SLIT2 | Slit homolog 2 protein | Thought to act as molecular guidance cue in cellular migration, and function appears to be mediated by interaction with roundabout homolog receptors. |
| SLIT3 | Slit homolog 3 protein | May act as molecular guidance cue in cellular migration, and function may be mediated by interaction with roundabout homolog receptors. |
| TBC1D1 | TBC1 domain family member 1 | May act as a GTPase-activating protein for Rab family protein(s). |
| ZMYM2 | Zinc finger MYM-type protein 2 | Involved in the negative regulation of transcription. |
| SRGAP1 | SLIT-ROBO Rho GTPase-activating protein 1 | GTPase-activating protein for RhoA and Cdc42 small GTPases. |
| CHD1L | ATP-dependent chromatin remodeler CHD1L | ATP-dependent chromatin remodeler that mediates chromatin-remodeling following DNA damage. |
| TSHZ3 | Teashirt homolog 3 | Transcriptional regulator involved in developmental processes. |
| LIFR | Leukemia inhibitory factor receptor | Signal-transducing molecule. |
| TBX6 | T-box transcription factor TBX6 | T-box transcription factor that plays an essential role in the determination of the fate of axial stem cells: neural vs mesodermal. |
| UPK3A | Uroplakin-3a | Component of the asymmetric unit membrane (AUM); a highly specialized biomembrane elaborated by terminally differentiated urothelial cells. |
| BCORL1 | BCL-6 corepressor-like protein 1 | Transcriptional corepressor. |
| DLG5 | Disks large homolog 5 | Acts as a regulator of the Hippo signaling pathway. |
| SHROOM4 | Protein Shroom4 | Probable regulator of cytoskeletal architecture that plays an important role in development. |
| TBC1D31 | TBC1 domain family member 31 | Molecular adapter which is involved in cilium biogenesis. |
| ARHGEF6 | Rho guanine nucleotide exchange factor 6 | Acts as a RAC1 guanine nucleotide exchange factor (GEF). |
| ROBO1 | Roundabout homolog 1 | Receptor for SLIT1 and SLIT2 that mediates cellular responses to molecular guidance cues in cellular migration, including axonal navigation at the ventral midline of the neural tube and projection of axons to different regions during neuro… |
| ROBO2 | Roundabout homolog 2 | Receptor for SLIT2, and probably SLIT1, which are thought to act as molecular guidance cue in cellular migration, including axonal navigation at the ventral midline of the neural tube and projection of axons to different regions during neu… |
| SALL1 | Sal-like protein 1 | Transcriptional repressor involved in organogenesis. |
| SOX5 | Transcription factor SOX-5 | Transcription factor involved in chondrocytes differentiation and cartilage formation. |
| TBX18 | T-box transcription factor TBX18 | Acts as a transcriptional repressor involved in developmental processes of a variety of tissues and organs, including the heart and coronary vessels, the ureter and the vertebral column. |
| HNF1B | Hepatocyte nuclear factor 1-beta | Transcription factor that binds to the inverted palindrome 5’-GTTAATNATTAAC-3'. |
| MED12 | Mediator of RNA polymerase II transcription subunit 12 | Component of the Mediator complex, a coactivator involved in the regulated transcription of nearly all RNA polymerase II-dependent genes. |
| HSP90B2P | Putative endoplasmin-like protein | Putative molecular chaperone. |
| TRIO | Triple functional domain protein | Guanine nucleotide exchange factor (GEF) for RHOA and RAC1 GTPases. |
| TRPS1 | Zinc finger transcription factor Trps1 | Transcriptional repressor. |
| TSC2 | Tuberin | Catalytic component of the TSC-TBC complex, a multiprotein complex that acts as a negative regulator of the canonical mTORC1 complex, an evolutionarily conserved central nutrient sensor that stimulates anabolic reactions and macromolecule… |
| GET1 | Guided entry of tail-anchored proteins factor 1 | Required for the post-translational delivery of tail-anchored (TA) proteins to the endoplasmic reticulum (ER). |
| CACNA1D | Voltage-dependent L-type calcium channel subunit alpha-1D | Voltage-sensitive calcium channels (VSCC) mediate the entry of calcium ions into excitable cells and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, gene exp… |
| SHANK3 | SH3 and multiple ankyrin repeat domains protein 3 | Major scaffold postsynaptic density protein which interacts with multiple proteins and complexes to orchestrate the dendritic spine and synapse formation, maturation and maintenance. |
| ACTG1 | Actin, cytoplasmic 2 | Actins are highly conserved proteins that are involved in various types of cell motility and are ubiquitously expressed in all eukaryotic cells. |
| GATA5 | Transcription factor GATA-5 | Transcription factor required during cardiovascular development. |
| SALL4 | Sal-like protein 4 | Transcription factor with a key role in the maintenance and self-renewal of embryonic and hematopoietic stem cells. |
| TRAP1 | Heat shock protein 75 kDa, mitochondrial | Chaperone that expresses an ATPase activity. |
| CHD5 | ATP-dependent chromatin remodeler CHD5 | ATP-dependent chromatin-remodeling factor that binds DNA through histones and regulates gene transcription. |
| CDON | Cell adhesion molecule-related/down-regulated by oncogenes | Component of a cell-surface receptor complex that mediates cell-cell interactions between muscle precursor cells. |
| CDC5L | Cell division cycle 5-like protein | DNA-binding protein involved in cell cycle control. |
| KAT6B | Histone acetyltransferase KAT6B | Histone acetyltransferase which may be involved in both positive and negative regulation of transcription. |
| HPSE2 | Inactive heparanase-2 | Binds heparin and heparan sulfate with high affinity, but lacks heparanase activity. |
| KCNT1 | Potassium channel subfamily T member 1 | Sodium-activated K(+) channel. |
| NPHP4 | Nephrocystin-4 | Involved in the organization of apical junctions; the function is proposed to implicate a NPHP1-4-8 module. |
| FRAS1 | Extracellular matrix organizing protein FRAS1 | Involved in extracellular matrix organization. |
| BICC1 | Protein bicaudal C homolog 1 | Putative RNA-binding protein. |
| BCOR | BCL-6 corepressor | Transcriptional corepressor. |
| COL4A1 | Collagen alpha-1(IV) chain | Type IV collagen is the major structural component of glomerular basement membranes (GBM), forming a ‘chicken-wire’ meshwork together with laminins, proteoglycans and entactin/nidogen. |
| MED13 | Mediator of RNA polymerase II transcription subunit 13 | Component of the Mediator complex, a coactivator involved in the regulated transcription of nearly all RNA polymerase II-dependent genes. |
| FAT4 | Protocadherin Fat 4 | Cadherins are calcium-dependent cell adhesion proteins. |
| FREM1 | FRAS1-related extracellular matrix protein 1 | Extracellular matrix protein that plays a role in epidermal differentiation and is required for epidermal adhesion during embryonic development. |
| WDR62 | WD repeat-containing protein 62 | Required for cerebral cortical development. |
Protein-family classification
Druggable: 9 · Difficult: 32 · Unknown: 34 · Druggable fraction: 0.12
Family distribution
Cohort families vs a genome-wide background (hypergeometric, BH-FDR; fold = observed/expected). Counts kept; sorted by enrichment, so the catch-all Other/Unknown bucket no longer leads.
| Family | Genes | Fold | FDR |
|---|---|---|---|
| Scaffold/PPI | 14 | 3.2× | 7e-04 |
| Transcription factor | 18 | 2.0× | 0.012 |
| Ion channel | 2 | 3.0× | 0.388 |
| Antibody/Immunoglobulin | 4 | 1.6× | 0.511 |
| Other/Unknown | 34 | 0.8× | 0.999 |
| Protease | 1 | 0.5× | 0.999 |
| Kinase | 1 | 0.4× | 0.999 |
| Enzyme (other) | 1 | 0.2× | 0.999 |
Per-gene assignment
| Symbol | Family | Druggable? | EC | InterPro (top 3) |
|---|---|---|---|---|
| BMP7 | Other/Unknown | no | TGF-b_propeptide, TGF-b_C, TGF-beta-like | |
| SIX2 | Transcription factor | no | HD, Homeodomain-like_sf, Homeobox_CS | |
| SLIT2 | Other/Unknown | no | EGF-type_Asp/Asn_hydroxyl_site, LRRNT, Cys-rich_flank_reg_C | |
| SLIT3 | Other/Unknown | no | EGF-type_Asp/Asn_hydroxyl_site, LRRNT, Cys-rich_flank_reg_C | |
| TBC1D1 | Other/Unknown | no | Rab-GAP-TBC_dom, PTB/PI_dom, PH-like_dom_sf | |
| ZMYM2 | Transcription factor | no | Znf_MYM, TRASH_dom, ZMYM2-like_C | |
| SRGAP1 | Scaffold/PPI | no | RhoGAP_dom, FCH_dom, SH3_domain | |
| CHD1L | Other/Unknown | no | SNF2_N, Helicase_C-like, DNA/RNA_helicase_DEAH_CS | |
| TSHZ3 | Transcription factor | no | HD, Znf_C2H2_type, Teashirt_fam | |
| LIFR | Antibody/Immunoglobulin | yes | Hematopoietin_rcpt_Gp130_CS, FN3_dom, Ig-like_fold | |
| TBX6 | Transcription factor | no | TF_T-box, TF_Brachyury, p53-like_TF_DNA-bd_sf | |
| UPK3A | Other/Unknown | no | Uroplakin-3a, Uroplakin-3 | |
| VWA2 | Other/Unknown | no | EGF, EGF-like_Ca-bd_dom, VWF_A | |
| BCORL1 | Scaffold/PPI | no | Ankyrin_rpt, PUFD, Ankyrin_rpt-contain_sf | |
| DLG5 | Scaffold/PPI | no | CARD, SH3_domain, PDZ | |
| SHROOM4 | Scaffold/PPI | no | PDZ, ASD2_dom, Shroom_fam | |
| TBC1D31 | Scaffold/PPI | no | Rab-GAP-TBC_dom, WD40_rpt, WD40/YVTN_repeat-like_dom_sf | |
| ARHGEF6 | Scaffold/PPI | no | DH_dom, SH3_domain, CH_dom | |
| ROBO1 | Antibody/Immunoglobulin | yes | Ig_sub2, Ig_sub, FN3_dom | |
| ROBO2 | Antibody/Immunoglobulin | yes | Ig_sub2, Ig_sub, FN3_dom | |
| SALL1 | Transcription factor | no | Znf_C2H2_type, Znf_C2H2_sf, Sal_C2H2-zinc-finger | |
| SOX5 | Transcription factor | no | HMG_box_dom, HMG_box_dom_sf, SOX/SOX-like_TF | |
| TBX18 | Transcription factor | no | TF_T-box, p53-like_TF_DNA-bd_sf, TF_T-box_CS | |
| HNF1B | Transcription factor | no | HD, HNF1b_C, HNF-1_N | |
| MED12 | Other/Unknown | no | Mediator_Med12, Mediator_Med12_catenin-bd, Mediator_Med12_LCEWAV | |
| HSP90B2P | Other/Unknown | no | Hsp90_fam, Ribosomal_Su5_D2-typ_SF, HSP90_C | |
| TRIO | Kinase | yes | DH_dom, Prot_kinase_dom, CRAL-TRIO_dom | |
| TRPS1 | Transcription factor | no | Znf_GATA, Znf_C2H2_type, Znf_NHR/GATA | |
| TSC2 | Other/Unknown | no | Rap/Ran_GAP_dom, Tuberin, ARM-like | |
| GET1 | Other/Unknown | no | Get1, Helix_hairpin_bin_sf | |
| CACNA1D | Ion channel | yes | VDCCAlpha1, VDCC_L_a1su, LVDCC_a1dsu | |
| SHANK3 | Scaffold/PPI | no | SH3_domain, PDZ, SAM | |
| ACTG1 | Other/Unknown | no | Actin, Actin_CS, Actin/actin-like_CS | |
| GATA5 | Transcription factor | no | Znf_GATA, GATA_N, Znf_NHR/GATA | |
| SALL4 | Transcription factor | no | Znf_C2H2_type, Znf_C2H2_sf, Sal_C2H2-zinc-finger | |
| TRAP1 | Other/Unknown | no | Hsp90_fam, HATPase_dom, Ribosomal_Su5_D2-typ_SF | |
| CHD5 | Transcription factor | no | SNF2_N, Chromo/chromo_shadow_dom, Helicase_C-like | |
| CDON | Antibody/Immunoglobulin | yes | Ig_sub2, Ig_sub, FN3_dom | |
| CDC5L | Transcription factor | no | SANT/Myb, Homeodomain-like_sf, Myb_dom | |
| KAT6B | Transcription factor | no | 2.3.1.48 | Znf_PHD, HAT_MYST-type, Histone_H1/H5_H15 |
| HPSE2 | Other/Unknown | no | Glyco_hydro_79, GH_hydrolase_sf | |
| KCNT1 | Ion channel | yes | RCK_N, K_chnl_BK_asu, K_chnl_dom | |
| NPHP4 | Other/Unknown | no | NPHP4, Ig_NPHP4_4th, Ig_NPHP4_3rd | |
| FRAS1 | Other/Unknown | no | EGF, VWF_dom, Calx_beta | |
| BICC1 | Other/Unknown | no | SAM, KH_dom, KH_dom_type_1 | |
| BCOR | Scaffold/PPI | no | Ankyrin_rpt, BCOR, PUFD | |
| COL4A1 | Other/Unknown | no | Collagen_IV_NC, Collagen, CTDL_fold | |
| MED13 | Other/Unknown | no | Med13_C, MID_MedPIWI, Mediator_complx_sub13 | |
| FAT4 | Other/Unknown | no | EGF-type_Asp/Asn_hydroxyl_site, EGF, Laminin_G | |
| FREM1 | Other/Unknown | no | C-type_lectin-like, Calx_beta, C-type_lectin-like/link_sf |
Expression context
Cohort genes with no expression data: 0.
70 cohort genes are a single-cell marker in ≥1 SCXA experiment.
Breadth distribution (Bgee present_calls)
| Bucket | Genes |
|---|---|
| narrow (1-5 tissues) | 0 |
| moderate (6-20) | 0 |
| broad (>20) | 75 |
| unknown | 0 |
Top tissues across cohort
| Tissue | Cohort genes |
|---|---|
| ventricular zone | 12 |
| buccal mucosa cell | 8 |
| cortical plate | 8 |
| calcaneal tendon | 6 |
| cerebellar hemisphere | 5 |
| primordial germ cell in gonad | 5 |
| right uterine tube | 5 |
| sural nerve | 5 |
| bronchial epithelial cell | 5 |
| gastrocnemius | 4 |
| oocyte | 4 |
| sperm | 4 |
| medial globus pallidus | 4 |
| ganglionic eminence | 4 |
| renal medulla | 4 |
| male germ line stem cell (sensu Vertebrata) in testis | 4 |
| cerebellar cortex | 4 |
| right hemisphere of cerebellum | 4 |
| olfactory segment of nasal mucosa | 3 |
| vena cava | 3 |
Per-gene tissue summary (top 30)
| Symbol | Bgee breadth | FANTOM5 breadth | SCXA | Top tissues |
|---|---|---|---|---|
| BMP7 | 243 | broad | marker | pigmented layer of retina, ventricular zone, endometrium epithelium |
| SIX2 | 156 | broad | marker | olfactory segment of nasal mucosa, gastrocnemius, parotid gland |
| SLIT2 | 274 | ubiquitous | marker | lower lobe of lung, olfactory bulb, vena cava |
| SLIT3 | 254 | ubiquitous | marker | right coronary artery, popliteal artery, tibial artery |
| TBC1D1 | 280 | ubiquitous | marker | ventricular zone, body of uterus, muscle layer of sigmoid colon |
| ZMYM2 | 294 | ubiquitous | marker | sperm, oocyte, secondary oocyte |
| SRGAP1 | 236 | ubiquitous | marker | buccal mucosa cell, cortical plate, medial globus pallidus |
| CHD1L | 233 | ubiquitous | marker | primordial germ cell in gonad, C1 segment of cervical spinal cord, cerebellar hemisphere |
| TSHZ3 | 222 | ubiquitous | marker | cortical plate, right ovary, left ovary |
| LIFR | 269 | ubiquitous | marker | medial globus pallidus, globus pallidus, lateral globus pallidus |
| TBX6 | 166 | tissue_specific | marker | lower esophagus mucosa, buccal mucosa cell, diaphragm |
| UPK3A | 126 | broad | marker | gastrocnemius, mucosa of urinary bladder, muscle of leg |
| VWA2 | 122 | broad | marker | thymus, right uterine tube, olfactory segment of nasal mucosa |
| BCORL1 | 250 | ubiquitous | marker | cervix squamous epithelium, cardia of stomach, vena cava |
| DLG5 | 134 | ubiquitous | marker | ventricular zone, left adrenal gland cortex, right adrenal gland cortex |
| SHROOM4 | 190 | broad | marker | buccal mucosa cell, tendon of biceps brachii, left ventricle myocardium |
| TBC1D31 | 224 | ubiquitous | marker | secondary oocyte, oocyte, primordial germ cell in gonad |
| ARHGEF6 | 289 | ubiquitous | marker | biceps brachii, skeletal muscle tissue of biceps brachii, medial globus pallidus |
| ROBO1 | 287 | ubiquitous | marker | ventricular zone, ganglionic eminence, tibia |
| ROBO2 | 192 | broad | marker | ganglionic eminence, cortical plate, ventricular zone |
| SALL1 | 195 | broad | marker | ventricular zone, inferior vagus X ganglion, renal medulla |
| SOX5 | 221 | ubiquitous | marker | cortical plate, calcaneal tendon, synovial joint |
| TBX18 | 162 | ubiquitous | marker | right coronary artery, popliteal artery, tibial artery |
| HNF1B | 74 | broad | marker | metanephros cortex, adult mammalian kidney, kidney |
| MED12 | 281 | ubiquitous | marker | right adrenal gland cortex, right adrenal gland, left ovary |
| HSP90B2P | 108 | ubiquitous | marker | male germ line stem cell (sensu Vertebrata) in testis, primordial germ cell in gonad, sural nerve |
| TRIO | 279 | ubiquitous | marker | sural nerve, cortical plate, stromal cell of endometrium |
| TRPS1 | 284 | ubiquitous | marker | mammary duct, epithelium of mammary gland, calcaneal tendon |
| TSC2 | 282 | ubiquitous | marker | right hemisphere of cerebellum, cerebellar hemisphere, cerebellar cortex |
| GET1 | 292 | ubiquitous | marker | bronchial epithelial cell, substantia nigra pars compacta, epithelium of bronchus |
Protein interactions among cohort
Intra-cohort edges: 47.
Hub genes (top 10 by interactor count)
| Symbol | Interactor count |
|---|---|
| EFTUD2 | 8,471 |
| NOTCH1 | 7,411 |
| GATA3 | 5,990 |
| CDC5L | 5,930 |
| NOTCH2 | 5,266 |
| TRAP1 | 5,216 |
| JAG1 | 4,405 |
| DHX8 | 4,332 |
| TSC2 | 4,135 |
| SHANK3 | 3,702 |
Intra-cohort edges
| A | B | Sources |
|---|---|---|
| BCOR | BCORL1 | string_interaction |
| BCOR | FRAS1 | intact |
| BMP7 | SMAD6 | string_interaction |
| CACNA1D | SHANK3 | intact |
| CDC5L | DHX8 | biogrid_interaction |
| CDC5L | EFTUD2 | string_interaction |
| CHD1L | HPSE2 | string_interaction |
| DHX8 | EFTUD2 | string_interaction |
| DLG5 | SHROOM4 | intact |
| EFTUD2 | MED12 | biogrid_interaction |
| EFTUD2 | MED13 | biogrid_interaction |
| FAT4 | SHANK3 | intact |
| FOXC1 | SALL1 | intact |
| FRAS1 | FREM1 | string_interaction |
| FRAS1 | FREM2 | string_interaction |
| FRAS1 | HPSE2 | biogrid_interaction |
| FRAS1 | VWA2 | string_interaction |
| FREM1 | FREM2 | intact, string_interaction |
| FREM1 | VWA2 | string_interaction |
| FREM2 | VWA2 | string_interaction |
| GATA5 | NKX2-5 | string_interaction |
| JAG1 | NOTCH1 | intact, string_interaction |
| JAG1 | NOTCH2 | biogrid_interaction, string_interaction |
| JAG1 | NOTCH4 | string_interaction |
| MED12 | MED13 | biogrid_interaction, string_interaction |
| NKX2-5 | SALL1 | string_interaction |
| NKX2-5 | SALL4 | string_interaction |
| NKX2-5 | TBX18 | string_interaction |
| NKX2-5 | TBX6 | string_interaction |
| NOTCH1 | NOTCH4 | string_interaction |
| NPHP1 | NPHP3 | biogrid_interaction, string_interaction |
| NPHP1 | NPHP4 | biogrid_interaction, intact, string_interaction |
| NPHP1 | OFD1 | string_interaction |
| NPHP1 | TMEM231 | string_interaction |
| NPHP3 | NPHP4 | string_interaction |
| OFD1 | TBC1D31 | intact |
| ROBO1 | ROBO2 | intact |
| ROBO1 | SLIT2 | intact, string_interaction |
| ROBO1 | SLIT3 | string_interaction |
| ROBO1 | SRGAP1 | biogrid_interaction, intact, string_interaction |
| ROBO2 | SLIT2 | string_interaction |
| ROBO2 | SLIT3 | string_interaction |
| ROBO2 | SRGAP1 | string_interaction |
| SALL1 | SALL4 | intact |
| SALL1 | SIX2 | string_interaction |
| SLIT2 | SRGAP1 | string_interaction |
| SLIT3 | SRGAP1 | string_interaction |
Structural data
PDB: 46 · AlphaFold-only: 27 · No structure: 2
Cohort genes with PDB structures (top 30)
| Symbol | UniProt | PDB entries |
|---|---|---|
| ACE | P12821 | 97 |
| EFTUD2 | Q15029 | 68 |
| CDC5L | Q99459 | 37 |
| NOTCH1 | P46531 | 29 |
| TRAP1 | Q12931 | 24 |
| DHX8 | Q14562 | 14 |
| SALL4 | Q9UJQ4 | 13 |
| ROBO1 | Q9Y6N7 | 12 |
| KMT2D | O14686 | 11 |
| ACTG1 | P63261 | 10 |
| EMC1 | Q8N766 | 10 |
| CHD1L | Q86WJ1 | 7 |
| JAG1 | P78504 | 7 |
| LIFR | P42702 | 6 |
| ROBO2 | Q9HCK4 | 6 |
| CACNA1D | Q01668 | 6 |
| KCNT1 | Q5JUK3 | 6 |
| BCOR | Q6W2J9 | 5 |
| MED13 | Q9UHV7 | 5 |
| BMP7 | P18075 | 4 |
| SLIT2 | O94813 | 4 |
| TRIO | O75962 | 4 |
| GET1 | O00258 | 4 |
| COL4A1 | P02462 | 4 |
| NKX2-5 | P52952 | 4 |
| HNF1B | P35680 | 3 |
| MED12 | Q93074 | 3 |
| SHANK3 | Q9BYB0 | 3 |
| CDON | Q4KMG0 | 3 |
| KAT6B | Q8WYB5 | 3 |
AlphaFold-only cohort genes (top 30 by pLDDT)
| Symbol | UniProt | pLDDT |
|---|---|---|
| TMEM231 | Q9H6L2 | 88.65 |
| VWA2 | Q5GFL6 | 86.02 |
| HPSE2 | Q8WWQ2 | 82.90 |
| HSP90B2P | Q58FF3 | 82.17 |
| SLIT3 | O75094 | 80.48 |
| CTU2 | Q2VPK5 | 80.27 |
| UPK3A | O75631 | 78.77 |
| TBC1D31 | Q96DN5 | 76.36 |
| SIX2 | Q9NPC8 | 75.99 |
| FREM1 | Q5H8C1 | 75.75 |
| SRGAP1 | Q7Z6B7 | 73.49 |
| GREB1L | Q9C091 | 72.90 |
| NPHP4 | O75161 | 72.44 |
| SMAD6 | O43541 | 72.34 |
| GDF6 | Q6KF10 | 70.88 |
| OFD1 | O75665 | 68.41 |
| TBX6 | O95947 | 66.18 |
| ZMYM2 | Q9UBW7 | 61.50 |
| WDR62 | O43379 | 61.19 |
| TBX18 | O95935 | 61.09 |
| GATA5 | Q9BWX5 | 59.91 |
| SOX5 | P35711 | 58.95 |
| FOXC1 | Q12948 | 56.09 |
| SALL1 | Q9NSC2 | 49.54 |
| TRPS1 | Q9UHF7 | 49.12 |
| FRAS1 | Q86XX4 | |
| FREM2 | Q5SZK8 |
Function
Pathway analysis
Distinct Reactome pathways touched by cohort: 377. Enrichment computed across 85 evidence-associated genes (57 with Reactome annotation).
Pathways by enrichment
Over-representation of cohort genes vs the genome-wide background (hypergeometric test, Benjamini-Hochberg FDR; fold = observed/expected over 57 annotated cohort genes). Counts and members are kept as ground-truth; sorted by enrichment.
| Pathway | Cohort genes | Fold | FDR | Sample cohort genes |
|---|---|---|---|---|
| Formation of the ureteric bud | 7 | 61.0× | 5e-09 | SIX2, SLIT2, ROBO2, SALL1, FOXC1, PAX2, RET |
| Kidney development | 5 | 71.5× | 9e-07 | SIX2, SLIT2, ROBO2, SALL1, JAG1 |
| Developmental Biology | 17 | 4.3× | 2e-05 | BMP7, SIX2, SLIT2, SLIT3, SRGAP1, ROBO1, ROBO2, SALL1 (+9 more) |
| Regulation of commissural axon pathfinding by SLIT and ROBO | 4 | 66.8× | 3e-05 | SLIT2, SLIT3, ROBO1, ROBO2 |
| Defective LFNG causes SCDO3 | 3 | 120.2× | 9e-05 | NOTCH1, NOTCH2, NOTCH4 |
| Pre-NOTCH Processing in the Endoplasmic Reticulum | 3 | 100.2× | 1e-04 | NOTCH1, NOTCH2, NOTCH4 |
| Inactivation of CDC42 and RAC1 | 3 | 75.1× | 3e-04 | SLIT2, SRGAP1, ROBO1 |
| Nephron development | 3 | 46.2× | 0.002 | HNF1B, JAG1, PAX2 |
| Activation of RAC1 | 3 | 42.9× | 0.002 | SLIT2, ROBO1, PAK3 |
| Pre-NOTCH Processing in Golgi | 3 | 33.4× | 0.003 | NOTCH1, NOTCH2, NOTCH4 |
| Formation of the nephric duct | 3 | 33.4× | 0.003 | GATA3, PAX2, RET |
| Signaling by ROBO receptors | 5 | 10.9× | 0.003 | SLIT2, SLIT3, SRGAP1, ROBO1, ROBO2 |
| NOTCH4 Intracellular Domain Regulates Transcription | 3 | 30.1× | 0.004 | NOTCH1, NOTCH2, NOTCH4 |
| SLIT2:ROBO1 increases RHOA activity | 2 | 100.2× | 0.004 | SLIT2, ROBO1 |
| Regulation of cortical dendrite branching | 2 | 80.1× | 0.006 | ROBO1, ROBO2 |
| Axon guidance | 7 | 5.5× | 0.006 | SLIT2, SLIT3, SRGAP1, ROBO1, ROBO2, CACNA1D, ACTG1 |
| Netrin-1 signaling | 3 | 23.1× | 0.006 | SLIT2, SLIT3, ROBO1 |
| Notch-HLH transcription pathway | 3 | 21.5× | 0.007 | NOTCH1, NOTCH2, NOTCH4 |
| Nervous system development | 7 | 5.3× | 0.007 | SLIT2, SLIT3, SRGAP1, ROBO1, ROBO2, CACNA1D, ACTG1 |
| Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | 2 | 57.2× | 0.010 | JAG1, NOTCH1 |
| Formation of intermediate mesoderm | 2 | 50.1× | 0.012 | FOXC1, PAX2 |
| Role of ABL in ROBO-SLIT signaling | 2 | 44.5× | 0.015 | SLIT2, ROBO1 |
| RHOU GTPase cycle | 3 | 14.7× | 0.018 | DLG5, ARHGEF6, PAK3 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | 2 | 36.4× | 0.021 | JAG1, NOTCH4 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | 2 | 30.8× | 0.028 | SALL1, SALL4 |
| RUNX3 regulates NOTCH signaling | 2 | 28.6× | 0.031 | JAG1, NOTCH1 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | 3 | 11.3× | 0.032 | MED12, MED13, KMT2D |
| RAC1 GTPase cycle | 5 | 5.4× | 0.032 | SRGAP1, TRIO, JAG1, ARHGEF6, PAK3 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | 2 | 26.7× | 0.032 | JAG1, NOTCH1 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | 2 | 25.0× | 0.035 | HNF1B, NOTCH1 |
GO biological processes by enrichment
Over-representation of cohort genes vs the genome-wide background (hypergeometric test, Benjamini-Hochberg FDR; fold = observed/expected over 82 annotated cohort genes). Counts and members are kept as ground-truth; sorted by enrichment.
| GO term | Cohort genes | Fold | FDR | Sample cohort genes |
|---|---|---|---|---|
| aortic valve morphogenesis | 10 | 52.7× | 2e-12 | SLIT2, SLIT3, ROBO1, ROBO2, GATA5, NKX2-5, GATA3, JAG1 (+2 more) |
| kidney development | 12 | 20.6× | 3e-10 | SIX2, SALL1, HNF1B, UPK3A, BICC1, FREM2, ACE, GREB1L (+4 more) |
| pulmonary valve morphogenesis | 7 | 79.9× | 5e-10 | SLIT2, ROBO1, ROBO2, JAG1, SMAD6, NOTCH1, NOTCH2 |
| ureteric bud development | 7 | 38.9× | 1e-07 | BMP7, SLIT2, ROBO2, SALL1, FOXC1, SMAD6, RET |
| heart development | 12 | 11.5× | 1e-07 | BMP7, SALL1, MED12, TSC2, BICC1, BCOR, NKX2-5, FREM2 (+4 more) |
| anatomical structure morphogenesis | 9 | 15.3× | 1e-06 | SIX2, TBX6, FRAS1, FREM1, FREM2, FOXC1, GATA3, SMAD6 (+1 more) |
| positive regulation of transcription by RNA polymerase II | 22 | 4.0× | 2e-06 | BMP7, SALL1, TBX6, MED12, GATA5, SALL4, CDON, CDC5L (+14 more) |
| cell fate determination | 5 | 57.1× | 2e-06 | GATA3, JAG1, NOTCH2, NOTCH4, PAX2 |
| ventricular septum morphogenesis | 6 | 31.6× | 4e-06 | SLIT2, SLIT3, ROBO1, ROBO2, NKX2-5, NOTCH1 |
| branching morphogenesis of an epithelial tube | 5 | 44.7× | 8e-06 | BMP7, SLIT2, HNF1B, NOTCH1, PKD1 |
| positive regulation of DNA-templated transcription | 15 | 5.1× | 2e-05 | BMP7, SALL1, TBX18, HNF1B, MED12, KAT6B, MED13, NKX2-5 (+7 more) |
| axon guidance | 9 | 9.9× | 2e-05 | BMP7, SLIT2, SLIT3, ROBO2, TRIO, GATA3, NOTCH1, NOTCH2 (+1 more) |
| ureter maturation | 3 | 154.1× | 3e-05 | GATA3, PAX2, RET |
| apoptotic process involved in luteolysis | 3 | 154.1× | 3e-05 | SLIT2, SLIT3, ROBO2 |
| cardiac septum morphogenesis | 4 | 58.7× | 3e-05 | BMP7, NKX2-5, JAG1, NOTCH1 |
| negative regulation of transcription by RNA polymerase II | 18 | 3.9× | 3e-05 | SALL1, TBX18, TBX6, HNF1B, TRPS1, GATA5, SALL4, BCOR (+10 more) |
| atrioventricular node development | 3 | 102.8× | 1e-04 | NKX2-5, NOTCH1, NOTCH2 |
| Roundabout signaling pathway | 3 | 102.8× | 1e-04 | SLIT2, SLIT3, ROBO1 |
| ureter development | 3 | 102.8× | 1e-04 | TBX18, NPHP3, PAX2 |
| positive regulation of Notch signaling pathway | 5 | 21.4× | 2e-04 | ROBO1, ROBO2, GATA5, JAG1, NOTCH1 |
| negative regulation of chemokine-mediated signaling pathway | 3 | 88.1× | 2e-04 | SLIT2, SLIT3, ROBO1 |
| heart induction | 3 | 77.1× | 2e-04 | ROBO1, ROBO2, GATA5 |
| mesenchymal to epithelial transition involved in metanephros morphogenesis | 3 | 77.1× | 2e-04 | SIX2, SALL1, PAX2 |
| mesodermal cell fate specification | 3 | 77.1× | 2e-04 | SIX2, TBX6, PAX2 |
| negative regulation of canonical Wnt signaling pathway | 7 | 10.1× | 2e-04 | TBX18, CDON, NPHP4, BICC1, NKX2-5, NOTCH1, NPHP3 |
| outflow tract septum morphogenesis | 4 | 31.6× | 3e-04 | ROBO1, ROBO2, NKX2-5, SMAD6 |
| positive regulation of smooth muscle cell differentiation | 3 | 68.5× | 3e-04 | NOTCH1, NOTCH2, NOTCH4 |
| genitalia development | 3 | 61.6× | 5e-04 | HNF1B, PKD1, PTPN11 |
| metanephric collecting duct development | 3 | 61.6× | 5e-04 | DLG5, PAX2, PKD1 |
| mesonephros development | 3 | 56.0× | 6e-04 | BMP7, GATA3, PAX2 |
Therapeutics
Drug target analysis
Approved (phase 4): 3 · Phase ≥3: 4 · Phased (≥1): 7 · Undrugged: 68
Druggability breadth: 32 of 85 evidence-associated genes (38%) have a ChEMBL target (buckets above are over the deeply-mined display cohort).
Genes with an approved drug
The molecule shown is one approved compound that hits the gene — not necessarily a drug of choice or one indicated for this disease.
| Symbol | Example approved molecule |
|---|---|
| CACNA1D | BEPRIDIL |
| KCNT1 | BEPRIDIL |
| ACE | TELMISARTAN |
Top cohort targets by molecule count
| Symbol | Molecules | Max phase |
|---|---|---|
| CACNA1D | 48 | 4 |
| ACE | 31 | 4 |
| TRAP1 | 9 | 3 |
| KCNT1 | 2 | 4 |
| MED12 | 1 | 2 |
| EFTUD2 | 1 | 2 |
| NOTCH1 | 1 | 2 |
| BMP7 | 0 | 0 |
| SIX2 | 0 | 0 |
| SLIT2 | 0 | 0 |
Drugs targeting cohort genes (top 30)
| Molecule | Max phase | Targets in cohort |
|---|---|---|
| BEPRIDIL | 4 | CACNA1D, KCNT1 |
| IMIPRAMINE | 4 | CACNA1D |
| HALOFANTRINE | 4 | CACNA1D |
| DROPERIDOL | 4 | CACNA1D |
| SAQUINAVIR | 4 | CACNA1D |
| DULOXETINE | 4 | CACNA1D |
| DIAZEPAM | 4 | CACNA1D |
| SERTINDOLE | 4 | CACNA1D |
| QUINIDINE | 4 | CACNA1D, KCNT1 |
| LAMIVUDINE | 4 | CACNA1D |
| PIMOZIDE | 4 | CACNA1D |
| PHENYTOIN | 4 | CACNA1D |
| TERFENADINE | 4 | CACNA1D |
| CISAPRIDE | 4 | CACNA1D |
| SOLIFENACIN | 4 | CACNA1D |
| NIFEDIPINE | 4 | CACNA1D |
| DILTIAZEM | 4 | CACNA1D |
| NILOTINIB | 4 | CACNA1D |
| ASTEMIZOLE | 4 | CACNA1D |
| TERODILINE | 4 | CACNA1D |
| CLOZAPINE | 4 | CACNA1D |
| MIBEFRADIL | 4 | CACNA1D |
| DOFETILIDE | 4 | CACNA1D |
| THIORIDAZINE | 4 | CACNA1D |
| PAROXETINE | 4 | CACNA1D |
| DONEPEZIL | 4 | CACNA1D |
| IBUTILIDE | 4 | CACNA1D |
| SUNITINIB | 4 | CACNA1D |
| HALOPERIDOL | 4 | CACNA1D |
| DASATINIB | 4 | CACNA1D |
Bioactivity and enzyme data
Enzyme cohort genes (≥1 EC): 3.
Cohort genes with ChEMBL bioactivity (full, sorted by assay count)
| Symbol | Assays | Type breakdown |
|---|---|---|
| ACE | 304 | Binding:288, Functional:8, ADMET:5, Unclassified:3 |
| CACNA1D | 233 | Binding:145, Functional:81, Toxicity:5, ADMET:2 |
| TRAP1 | 94 | Binding:94 |
| KCNT1 | 24 | Binding:24 |
| NOTCH1 | 23 | Binding:19, ADMET:4 |
| KAT6B | 22 | Binding:20, Functional:2 |
| SALL4 | 12 | Binding:12 |
| KMT2D | 11 | Binding:11 |
| EFTUD2 | 8 | Binding:8 |
| LIFR | 6 | Binding:6 |
| ARHGEF6 | 6 | Binding:6 |
| MED12 | 6 | Binding:6 |
| CHD1L | 4 | Binding:4 |
| TRIO | 2 | Binding:2 |
| BCOR | 2 | Binding:2 |
| NOTCH2 | 2 | Binding:2 |
| NOTCH4 | 2 | Binding:2 |
| TSC2 | 1 | Binding:1 |
| CDC5L | 1 | Binding:1 |
| DHX8 | 1 | Binding:1 |
| EMC1 | 1 | Binding:1 |
| JAG1 | 1 | Binding:1 |
Cohort enzymes (BRENDA EC)
| Symbol | EC numbers | Names |
|---|---|---|
| KAT6B | 2.3.1.48 | histone acetyltransferase |
| ACE | 3.4.15.1 | peptidyl-dipeptidase A |
| DHX8 | 3.6.4.13 | RNA helicase |
Cohort genes with high screening signal
≥100 ChEMBL assays — a studied-ness signal; see Therapeutics for approved-drug status.
| Symbol | ChEMBL assays |
|---|---|
| CACNA1D | 233 |
| ACE | 304 |
Pharmacogenomics
Cohort genes with a PharmGKB record: 73; with CPIC/DPWG dosing guidelines: 0.
No cohort gene has a CPIC/DPWG genotype-guided dosing guideline (PharmGKB).
Chemical tractability of cohort targets
30 approved/phased compounds have measured bioactivity against a cohort gene (and aren’t yet in disease-level trials). This is a research / tractability signal, NOT a therapeutic recommendation — a bioactivity row often reflects off-target or screening binding (e.g. promiscuous kinase inhibitors against a cohort kinase), implying no disease mechanism.
| Compound | Max phase | Cohort target (bioactivity) |
|---|---|---|
| BEPRIDIL | 4 | CACNA1D, KCNT1 |
| IMIPRAMINE | 4 | CACNA1D |
| HALOFANTRINE | 4 | CACNA1D |
| DROPERIDOL | 4 | CACNA1D |
| SAQUINAVIR | 4 | CACNA1D |
| DULOXETINE | 4 | CACNA1D |
| DIAZEPAM | 4 | CACNA1D |
| SERTINDOLE | 4 | CACNA1D |
| QUINIDINE | 4 | CACNA1D, KCNT1 |
| LAMIVUDINE | 4 | CACNA1D |
| PIMOZIDE | 4 | CACNA1D |
| PHENYTOIN | 4 | CACNA1D |
| TERFENADINE | 4 | CACNA1D |
| CISAPRIDE | 4 | CACNA1D |
| SOLIFENACIN | 4 | CACNA1D |
| NIFEDIPINE | 4 | CACNA1D |
| DILTIAZEM | 4 | CACNA1D |
| NILOTINIB | 4 | CACNA1D |
| ASTEMIZOLE | 4 | CACNA1D |
| TERODILINE | 4 | CACNA1D |
| CLOZAPINE | 4 | CACNA1D |
| MIBEFRADIL | 4 | CACNA1D |
| DOFETILIDE | 4 | CACNA1D |
| THIORIDAZINE | 4 | CACNA1D |
| PAROXETINE | 4 | CACNA1D |
| DONEPEZIL | 4 | CACNA1D |
| IBUTILIDE | 4 | CACNA1D |
| SUNITINIB | 4 | CACNA1D |
| HALOPERIDOL | 4 | CACNA1D |
| DASATINIB | 4 | CACNA1D |
Druggability pyramid
Cohort genes binned by druggability tier (high → low):
| Tier | Definition | Genes | Symbols |
|---|---|---|---|
| A | Approved (phase 4 drug) | 3 | CACNA1D, KCNT1, ACE |
| B | Phased (≥1) drug, not yet approved | 4 | MED12, TRAP1, EFTUD2, NOTCH1 |
| C | Druggable family + PDB, no drug | 6 | LIFR, ROBO1, ROBO2, TRIO, CDON, DHX8 |
| D | Druggable family + AlphaFold only, no drug | 0 | |
| E | Difficult family or no structure, no drug | 62 | BMP7, SIX2, SLIT2, SLIT3, TBC1D1, ZMYM2, SRGAP1, CHD1L, TSHZ3, TBX6 (+52 more) |
Undrugged target profiles
68 cohort genes are undrugged. Ranked by ‘starting-point quality’ (assay depth + drugged-partner adjacency).
| Symbol | ChEMBL assays | Drugged partners (top 3) |
|---|---|---|
| MED13 | 0 | MED12 |
| JAG1 | 1 | NOTCH1 |
| BMP7 | 0 | — |
| SIX2 | 0 | — |
| SLIT2 | 0 | — |
| SLIT3 | 0 | — |
| TBC1D1 | 0 | — |
| ZMYM2 | 0 | — |
| SRGAP1 | 0 | — |
| CHD1L | 4 | — |
| TSHZ3 | 0 | — |
| LIFR | 6 | — |
| TBX6 | 0 | — |
| UPK3A | 0 | — |
| VWA2 | 0 | — |
| BCORL1 | 0 | — |
| DLG5 | 0 | — |
| SHROOM4 | 0 | — |
| TBC1D31 | 0 | — |
| ARHGEF6 | 6 | — |
| ROBO1 | 0 | — |
| ROBO2 | 0 | — |
| SALL1 | 0 | — |
| SOX5 | 0 | — |
| TBX18 | 0 | — |
| HNF1B | 0 | — |
| HSP90B2P | 0 | — |
| TRIO | 2 | — |
| TRPS1 | 0 | — |
| TSC2 | 1 | — |
Clinical trials & evidence
Clinical trials
Clinical trials: 4.
Phase distribution (across all retrieved trials)
| Phase | Trials |
|---|---|
| PHASE1 | 2 |
| Not specified | 2 |
Top trials by phase / activity
| NCT | Phase | Status | Title |
|---|---|---|---|
| NCT04115345 | PHASE1 | COMPLETED | A Study of a Renal Autologous Cell Therapy (REACT) in Patients With Chronic Kidney Disease (CKD) From Congenital Anomalies of the Kidney and Urinary Tract (CAKUT). |
| NCT05694169 | PHASE1 | TERMINATED | A Study of Participants With Chronic Kidney Disease Previously Treated With REACT |
| NCT06921733 | Not specified | RECRUITING | Ultrasound Localization Microscopy in Patient With Congenital Anomalies of the Kidney and Urinary Tract (CAKUT) |
| NCT04537364 | Not specified | COMPLETED | Prediction of Renal Parenchymal Damage of CAKUT |
Related Atlas pages
- Cohort genes: BMP7, SIX2, SLIT2, SLIT3, TBC1D1, ZMYM2, SRGAP1, CHD1L, TSHZ3, LIFR, TBX6, UPK3A, VWA2, BCORL1, DLG5, SHROOM4, TBC1D31, ARHGEF6, ROBO1, ROBO2, SALL1, SOX5, TBX18, HNF1B, MED12, TRIO, TRPS1, TSC2, GET1, CACNA1D, SHANK3, ACTG1, GATA5, SALL4, TRAP1, CHD5, CDON, CDC5L, KAT6B, HPSE2, KCNT1, NPHP4, FRAS1, BICC1, BCOR, COL4A1, MED13, FAT4, FREM1, WDR62, NKX2-5, FREM2, OFD1, ACE, DHX8, CTU2, EMC1, DNAH9, EFTUD2, GREB1L, TMEM231, FOXC1, GATA3, GDF6, PKD1-AS1, JAG1, SMAD6, KMT2D, NOTCH1, NOTCH2, NOTCH4, NPHP1, NPHP3